Suppr超能文献

生物反馈疗法治疗直肠癌术后前切除综合征的疗效。

Effectiveness of biofeedback therapy in the treatment of anterior resection syndrome after rectal cancer surgery.

机构信息

Department of Colon and Rectal Surgery, University of Ulsan College of Medicine and Asan Medical Center, Seoul, Korea.

出版信息

Dis Colon Rectum. 2011 Sep;54(9):1107-13. doi: 10.1097/DCR.0b013e318221a934.

Abstract

BACKGROUND

Although anterior resection syndrome commonly occurs after anal sphincter-saving surgery, no standard treatment option is currently available.

OBJECTIVE

The aim of the present study was to evaluate the clinical effectiveness of biofeedback in patients with anterior resection syndrome after sphincter-saving surgery for rectal cancer.

DESIGN

This study was a retrospective review of data collected during the course of treatment.

SETTINGS

Patients were treated at a teaching hospital (Asan Medical Center) in Seoul, Korea, from January 2003 through December 2008.

PATIENTS

Patients who received biofeedback therapy for anterior resection syndrome after rectal cancer surgery were included.

MAIN OUTCOME MEASURES

The Cleveland Clinic Florida fecal incontinence score, number of bowel movements per day, a visual analog scale for assessing patient satisfaction, and anorectal manometry were used to assess outcome of biofeedback treatment.

RESULTS

: After biofeedback therapy, significant improvements were observed in fecal incontinence score (P < .001), number of bowel movements (P < .001), and anorectal manometry data (maximum resting pressure, P = .010; maximum squeeze pressure, P = .006; rectal capacity, P = .003). Compared with patients who started biofeedback treatment less than 18 months after surgery, those who started biofeedback at 18 months or longer after surgery showed greater improvements in fecal incontinence score (P = .032). Only patients with fecal incontinence as the primary symptom showed significant improvements in all variables, including fecal incontinence score, P < .001; defecation frequency, P < .001; and anorectal manometry (maximum resting pressure, P = .027; maximum squeeze pressure, P = .021; rectal capacity, P = .004). Patients who received radiation therapy in addition to surgery reported a significantly higher satisfaction score than those receiving surgery alone (P = .041).

LIMITATIONS

This is a nonrandomized retrospective study. Anorectal manometry was not regularly performed in all patients.

CONCLUSIONS

Biofeedback therapy produced significant clinical benefits for patients with severe fecal incontinence and may be an effective treatment for patients with anterior resection syndrome after surgery for rectal cancer.

摘要

背景

尽管肛门括约肌保肛手术后常发生前切除综合征,但目前尚无标准的治疗选择。

目的

本研究旨在评估生物反馈在直肠癌保肛手术后前切除综合征患者中的临床疗效。

设计

这是一项回顾性数据收集研究。

地点

患者在韩国首尔的一家教学医院(Asan Medical Center)接受治疗。

患者

接受生物反馈治疗的直肠癌手术后前切除综合征患者。

主要观察指标

克利夫兰诊所佛罗里达粪便失禁评分、每日排便次数、评估患者满意度的视觉模拟评分和肛门直肠测压用于评估生物反馈治疗的结果。

结果

生物反馈治疗后,粪便失禁评分(P <.001)、排便次数(P <.001)和肛门直肠测压数据(最大静息压,P =.010;最大收缩压,P =.006;直肠容量,P =.003)均显著改善。与手术后 18 个月内开始生物反馈治疗的患者相比,手术后 18 个月或更长时间开始生物反馈治疗的患者粪便失禁评分改善更显著(P =.032)。仅有粪便失禁为主要症状的患者在所有变量中均显示出显著改善,包括粪便失禁评分(P <.001)、排便频率(P <.001)和肛门直肠测压(最大静息压,P =.027;最大收缩压,P =.021;直肠容量,P =.004)。接受手术加放疗的患者报告的满意度评分明显高于仅接受手术的患者(P =.041)。

局限性

这是一项非随机回顾性研究。并非所有患者均常规进行肛门直肠测压。

结论

生物反馈治疗对严重粪便失禁患者具有显著的临床获益,可能是直肠癌保肛手术后前切除综合征的有效治疗方法。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验